関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | 3-Aminopyridine | HCID 10009 | — |
| 反応物 | 3-Bromopyridine | HCID 12286 | — |
| 試薬 | Sodium t-butoxide | HCID 23676156 | — |
| 触媒 | Palladium (II) acetate | HCID 4144353 | — |
| 触媒 | (R)-(-)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine;Ferrocene, 1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-, (2R)- | HCID 144543273 | — |
| 溶媒 | 1,2-Dimethoxyethane | HCID 8071 | — |
| 生成物 | N-pyridin-3-ylpyridin-3-amine | HCID 598775 | 9.97% |
反応手順
Stock solution: 2.43 M solution of CyPF-tBu/Pd(OAc)2 (1:1) in DME. pyridin-3-amine (3.57 g, 37.98 mmol) was dissolved in DME (10 mL). To the mixture was added 10 mL of stock solution, and sodium tert-butoxide (4.26 g, 44.30 mmol). 5 min later, to the mixtue was added a solution of 3-bromopyridine (3.05 mL, 31.65 mmol) in DME (10 mL). The mixture was heated at 100 °C overnight. LCMS1 showed the result after 1 h heating. LCMS2 showed the result after 18 h heating, which showed the product formation, and the starting material 3-BrPy. LCMS3 showed the result after 40 h heating. LCMS4 was after 60h. To the mixture was added 50 mL DCM and acetic acid (2 mL, 34.94 mmol). The mixture was stirred for 10 min, and then was filtered. The filtrate was concentrated, and the compound was purified by preparative HPLC on a XBridge C18 column (10 µm 250x50 ID mm) using a gradient of 0-60% acetonitrile in H2O/ACN/NH3 95/5/0.2 buffer over 20 minutes with a flow of 100 mL/min. The compounds were detected by UV at 254nm (LCMS5). After freezing-dried overnight, product dipyridin-3-ylamine (0.540 g, 9.97 %) was obtained.
情報源と証拠
| 出典データセット | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-acf9860e722c4b4598d1b2c19d9e27a1 |
|---|
| 出典メモ | 750 AstraZeneca ELN dataset |
|---|